Prof. Ashfaq Shuaib, MD, FRCPC, FAHA, is an internationally recognized neurologist and academic specializing in stroke medicine, cerebrovascular disease, and neurological research. He has held senior academic and clinical leadership positions at the University of Alberta in Edmonton, Canada, and previously served as Director of the Qatar Neuroscience Institute at Hamad Medical Corporation in Doha, Qatar.
Prof. Shuaib earned his Bachelor of Medicine and Bachelor of Surgery degree from Khyber Medical College in Pakistan in 1980. He subsequently completed postgraduate training in internal medicine and neurology at the University of Calgary in Canada between 1983 and 1988. He continued his specialized research training in cerebrovascular disease at the University of Western Ontario and Duke University School of Medicine in the United States.
In 1989, he joined the University of Saskatchewan as an Assistant Professor of Medicine and Neurology. He advanced to full professor in 1995 and held several academic leadership positions, including Residency Program Director, Director of the Saskatchewan Stroke Research Centre, and Director of a World Health Organization centre.
In September 1997, Prof. Shuaib joined the University of Alberta as Professor of Medicine and Director of the Division of Neurology. He subsequently established the university's Stroke Program, Stroke Fellowship, and Stroke Clinic, helping strengthen its clinical and academic capabilities in stroke care.
In January 2014, he moved to Doha to lead the Qatar Neuroscience Institute at Hamad Medical Corporation. During his tenure, he contributed to the development of specialized neuroscience services and regional clinical research initiatives, including collaborative studies involving patients with transient ischemic attacks and minor stroke.
His research focuses on the mechanisms of cerebral ischemia, acute stroke treatment, and clinical trials investigating therapies for cerebrovascular disease. He has authored hundreds of peer-reviewed scientific publications and has contributed to major multicentre clinical trials evaluating potential treatments for acute ischemic stroke.
Career and Achievement Timeline
- 1980 — Medical Degree: Graduated from Khyber Medical College, Pakistan, with an MBBS degree.
- 1983–1988 — Postgraduate Training: Completed postgraduate training in internal medicine and neurology at the University of Calgary, Canada.
- Late 1980s — Cerebrovascular Research: Undertook specialized research training at the University of Western Ontario and Duke University School of Medicine.
- 1989 — Academic Appointment: Joined the University of Saskatchewan as Assistant Professor of Medicine and Neurology.
- 1990–1995 — Residency Leadership: Served as Residency Program Director in the Division of Neurology and supervised medical trainees and research fellows.
- 1995 — Academic Promotion: Appointed full professor at the University of Saskatchewan.
- 1997 — University of Alberta: Joined as Professor of Medicine and Director of the Division of Neurology.
- Stroke Programme Development: Established the University of Alberta Stroke Program, Stroke Fellowship, and Stroke Clinic.
- 2007 — Continued Stroke Leadership: Stepped down as Director of the Division of Neurology while continuing to lead the university's Stroke Program.
- 2014 — Qatar Neuroscience Institute: Relocated to Doha to serve as Director of the Qatar Neuroscience Institute at Hamad Medical Corporation.
- Clinical Trial Leadership: Chaired steering committees for major multicentre stroke trials, including the SAINT II and SENTIS studies.
- Academic Research: Published extensively in peer-reviewed journals and contributed to clinical research on cerebral ischemia, acute stroke, and cerebrovascular disease.
Key Achievements
- Established a comprehensive stroke programme, stroke fellowship, and dedicated stroke clinic at the University of Alberta.
- Advanced academic training and mentorship for neurologists and stroke researchers.
- Led major clinical and academic neuroscience initiatives at Hamad Medical Corporation in Qatar.
- Chaired steering committees for the SAINT II and SENTIS multicentre clinical trials.
- Contributed to clinical research investigating the mechanisms of cerebral ischemia and potential treatments for acute stroke.
- Published hundreds of peer-reviewed scientific articles on stroke medicine and cerebrovascular disorders.
- Served on editorial boards and in editorial leadership roles for medical and neuroscience journals.
- Supported international research collaboration and specialist education in neurology.
Institutions and Professional Affiliations
- University of Alberta, Department of Medicine, Division of Neurology, Edmonton, Canada.
- Hamad Medical Corporation, Qatar Neuroscience Institute, Doha, Qatar — former Director.
- University of Saskatchewan, Department of Medicine and Neurology — former faculty member and academic leader.
- Khyber Medical College, Pakistan — medical education.
Research and Publications
Prof. Shuaib's research centres on cerebral ischemia, the pathophysiology of stroke, acute stroke treatment, and clinical trials in cerebrovascular disease. His work includes investigations of potential neuroprotective therapies and endovascular approaches to stroke treatment.
He has authored and co-authored numerous peer-reviewed publications and contributed to major clinical trials evaluating interventions for acute ischemic stroke. He has also served on the editorial boards of several medical journals, helping support the dissemination and review of neurological research.
Professional Recognition
- Recognized internationally for contributions to stroke medicine and cerebrovascular research.
- Appointed to senior academic and clinical leadership positions at major Canadian and Qatari medical institutions.
- Recognized for establishing stroke services and training programmes.
- Contributed to major multicentre clinical trials and international scientific collaboration.
Prof. Ashfaq Shuaib — Key Achievements
- Established the University of Alberta Stroke Program: Developed a comprehensive stroke service, including a dedicated stroke clinic and specialist fellowship programme.
- Advanced Neurology Education: Served as Residency Program Director and mentored neurology residents, fellows, and clinical researchers.
- Leadership at Qatar Neuroscience Institute: Served as Director of the Qatar Neuroscience Institute at Hamad Medical Corporation, contributing to the development of specialized neuroscience services in Qatar.
- Led Major Clinical Trials: Chaired steering committees for the SAINT II and SENTIS multicentre clinical trials investigating potential treatments for acute ischemic stroke.
- Contributions to Stroke Research: Conducted extensive research into cerebral ischemia, neuroprotection, and therapies for acute stroke.
- Extensive Scientific Publications: Authored and co-authored numerous peer-reviewed publications on stroke medicine, cerebrovascular disease, and neurological research.
- International Research Collaboration: Contributed to multidisciplinary and multicentre research initiatives advancing the understanding and treatment of stroke.
- Academic Leadership: Held senior academic appointments at the University of Saskatchewan and the University of Alberta, supporting clinical research and specialist education.
- Medical Journal Contributions: Served in editorial and peer-review roles supporting the publication and evaluation of neurological research.